Literature DB >> 12408538

Is any form of gender selection ethical?

Charles Hanson1, Lars Hamberger, Per Olof Janson.   

Abstract

In later years, sex selection has become of importance for prevention of X-linked diseases in families at risk. There is today a potential to perform sperm selection before fertilization by taking advantage of the chromosomal heterogamy of spermatozoa, and before implantation by preimplantation genetic diagnosis (PGD). The methods of sex determination by separating sperrmatozoa are, in our opinion, still not safe enough for routine clinical use. Apart from the technical problems and possible associated risks, which first must be better evaluated, the most critical questions are ethical or legal. We support the use of sex selection by PGD in X-linked severe disease, but due to the potential risks of misuse, we are not prepared to support a more liberal attitude as long as the discriminated sex in nearly all parts of the world are women.

Entities:  

Keywords:  Genetics and Reproduction

Mesh:

Year:  2002        PMID: 12408538      PMCID: PMC3455541          DOI: 10.1023/a:1016867824542

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  4 in total

1.  Clinical experience with flow cytometric separation of human X- and Y-chromosome bearing sperm.

Authors:  E F Fugger
Journal:  Theriogenology       Date:  1999-12       Impact factor: 2.740

2.  ESHRE Preimplantation Genetic Diagnosis Consortium: data collection III (May 2001).

Authors: 
Journal:  Hum Reprod       Date:  2002-01       Impact factor: 6.918

3.  Biopsy of human preimplantation embryos and sexing by DNA amplification.

Authors:  A H Handyside; J K Pattinson; R J Penketh; J D Delhanty; R M Winston; E G Tuddenham
Journal:  Lancet       Date:  1989-02-18       Impact factor: 79.321

4.  Preimplantation genetic diagnosis (PGD): the Gothenburg experience.

Authors:  C Hanson; A H Jakobsson; A Sjögren; K Lundin; L Nilsson; J Wahlström; T Hardarson; J Stevic; C Darnfors; P O Janson; M Wikland; L Hamberger
Journal:  Acta Obstet Gynecol Scand       Date:  2001-04       Impact factor: 3.636

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.